BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7701792)

  • 21. Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma.
    Ohno R; Yoshinaga K; Fujita T; Hasegawa K; Iseki H; Tsunozaki H; Ichikawa W; Nihei Z; Sugihara K
    Cancer; 2001 May; 91(10):1876-81. PubMed ID: 11346869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Histogenesis and morphological characteristics of stomach cancer].
    Dikshteĭn EA; Vasilenko IV
    Arkh Patol; 1977 Jan; 39(1):11-7. PubMed ID: 843231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lactic dehydrogenase levels in serum and gastric juice in patients with gastric carcinoma.
    Durrani HA; Bashir Ahmad S; Kaul DK
    J Assoc Physicians India; 1979 Nov; 27(11):1009-13. PubMed ID: 232702
    [No Abstract]   [Full Text] [Related]  

  • 24. [Early cancer of the stomach. 2. Pathology].
    Oehlert W
    Z Allgemeinmed; 1974 Jul; 50(20):907-11. PubMed ID: 4367620
    [No Abstract]   [Full Text] [Related]  

  • 25. [Current histological classification and morphological and statistical characteristics of stomach cancer].
    Zolotarevskiĭ VB; Khon ChV
    Arkh Patol; 1984; 46(6):27-33. PubMed ID: 6089710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Circular lesions of the stomach in cancer].
    Akhmetov MSh
    Vopr Onkol; 1971; 17(6):24-8. PubMed ID: 4333113
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pathological studies of multiple submucosal gastric gland lesions in thirty-eight cases].
    Wada R; Abe H; Taki K; Kuwabara N; Fukuda Y
    Gan No Rinsho; 1990 Apr; 36(5):615-20. PubMed ID: 2325267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cytological-histological correlations in stomach cancer].
    Czerniak B; Woyke S; Marlicz K
    Patol Pol; 1985; 36(3):217-28. PubMed ID: 3012446
    [No Abstract]   [Full Text] [Related]  

  • 29. [Proteolytic enzyme activity in stomach cancer patients with various prognoses].
    Kantsaliev AL; Kushlinskiĭ NE; Vasil'ev AV; Klimenkov AA
    Vopr Med Khim; 1994; 40(3):41-3. PubMed ID: 8079438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relation of heparanase mRNA expression and angiogenesis to the progression of gastric carcinoma].
    Ren XL; Zhu RZ; Wang LJ; Zhang ML; Li DH; Deng XQ
    Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):368-71. PubMed ID: 12921569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of cathepsin B and D in colorectal cancer: relationships with tumour budding.
    Guzińska-Ustymowicz K; Zalewski B; Kasacka I; Piotrowski Z; Skrzydlewska E
    Anticancer Res; 2004; 24(5A):2847-51. PubMed ID: 15517887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The histogenesis of stomach cancer].
    Vasilenko IV; Dikshteĭn EA
    Vopr Onkol; 1991; 37(6):643-51. PubMed ID: 1668829
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinicopathologic study of early-stage mucinous gastric carcinoma.
    Adachi Y; Yasuda K; Inomata M; Shiraishi N; Kitano S; Sugimachi K
    Cancer; 2001 Feb; 91(4):698-703. PubMed ID: 11241236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The prognostic value of cathepsin D in endometrial carcinoma].
    Köhler U; Langanke D; Sorger D; Martin R; Bilek K
    Zentralbl Gynakol; 1995; 117(3):148-52. PubMed ID: 7740849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastric carcinoma: expression of c-erbB-2/neu oncoprotein, epidermal growth factor receptor, cathepsin D, progesterone receptor and tumor associated glycoprotein-72 in different histological types.
    Peláez Buján Mdel C; Ruibal Morell A; Aza González J
    Rev Esp Enferm Dig; 1999 Dec; 91(12):826-37. PubMed ID: 10619912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Telomerase activity could be used as a marker for neoplastic transformation in gastric adenocarcinoma: but it does not have a prognostic significance.
    Gümüş-Akay G; Unal AE; Bayar S; Karadayi K; Elhan AH; Sunguroĝlu A; Tükün A
    Genet Mol Res; 2007 Feb; 6(1):41-9. PubMed ID: 17469053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical prognostic factors and expression of cathepsin D in endometrioid adenocarcinoma.
    Dvalishvili I; Charkviani L; Charkviani T; Turashvili G; Burkadze G
    Georgian Med News; 2005 Sep; (126):27-31. PubMed ID: 16234588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Superficial early cancer of the stomach].
    Gollub H; Möbius G
    Pathologe; 1988 Nov; 9(6):325-9. PubMed ID: 2853349
    [No Abstract]   [Full Text] [Related]  

  • 40. Cathepsin-D in human breast cancer: correlation with vascular invasion and other clinical and histopathological characteristics.
    Hähnel R; Harvey J; Robbins P; Sterrett G
    Anticancer Res; 1993; 13(6A):2131-5. PubMed ID: 8297125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.